Q1 2015

Source filing unavailable

Q1 2015 · —

Revenue

$34.20M

+306.6% vs Q1 2014

Net Income

-$4.96M

N/M vs Q1 2014

EPS Diluted

-$0.13

N/M vs Q1 2014

Operating Income-$5,195,000N/M

Operating Cash Flow-$25,585,000N/M

Free Cash Flowderived

Same quarter

Metric	Q1 2015	Q1 2014	Q1 2013	Q1 2012
Revenue	$34.20M	$8.41M	$6.27M	$6.27M
Net Income	-$4.96M	-$12.25M	-$7.23M	-$4.63M
EPS Diluted	-$0.13	-$0.39	-$2.47	-$1.98

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Agios Pharmaceuticals, Inc. · CIK 1439222 · Engraved from SEC EDGAR